| NCT03895658 |
Title: Safety and Feasibility of Individualized Low Amplitude Seizure Therapy (iLAST) |
https://ClinicalTrials.gov/show/NCT03895658 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2021-12-31 |
| NCT03406702 |
A Phase 2 Study of CX-8998 in Adolescents and Adults With Idiopathic Generalized Epilepsy With Absence Seizures |
https://ClinicalTrials.gov/show/NCT03406702 |
Completed |
Jazz Pharmaceuticals |
2019-03-29 |
| NCT03373383 |
Study to Test the Efficacy and Safety of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adults With Drug-resistant Epilepsy |
https://ClinicalTrials.gov/show/NCT03373383 |
Completed |
UCB Pharma |
2019-12-18 |
| NCT03370120 |
Study to Test the Safety and Efficacy of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adult Subjects With Drug-resistant Epilepsy |
https://ClinicalTrials.gov/show/NCT03370120 |
Enrolling by invitation |
UCB Pharma |
2022-07-31 |
| NCT03369093 |
RCT of Efficacy of Amoxicillin Over Ampicillin on Severe Pneumonia |
https://ClinicalTrials.gov/show/NCT03369093 |
Recruiting |
International Centre for Diarrhoeal Disease Research, Bangladesh |
2020-08-31 |
| NCT03826056 |
Neurology Inpatient Clinical Education Trial |
https://ClinicalTrials.gov/show/NCT03826056 |
Active, not recruiting |
Dartmouth-Hitchcock Medical Center |
2020-10-31 |
| NCT03361826 |
Magnetic Seizure Therapy for the Treatment of Borderline Personality Disorder |
https://ClinicalTrials.gov/show/NCT03361826 |
Recruiting |
Centre for Addiction and Mental Health |
2020-12-31 |
| NCT03360656 |
Transnasal Induction of Normothermia in Febrile Stroke Patients |
https://ClinicalTrials.gov/show/NCT03360656 |
Recruiting |
CoolTech LLC |
2020-07-31 |
| NCT03355300 |
Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures |
https://ClinicalTrials.gov/show/NCT03355300 |
Recruiting |
INSYS Therapeutics Inc |
2019-11-30 |
| NCT03340064 |
A Study of Levetiracetam as Monotherapy or Adjunctive Treatment of Partial Seizures in Pediatric Epileptic Subjects Ranging From 1 Month to Less Than 4 Years of Age |
https://ClinicalTrials.gov/show/NCT03340064 |
Recruiting |
UCB Pharma |
2023-08-31 |
| NCT03336242 |
Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures |
https://ClinicalTrials.gov/show/NCT03336242 |
Recruiting |
INSYS Therapeutics Inc |
2019-06-30 |
| NCT03329703 |
Project UPLIFT for Psychogenic Non-Epileptic Seizures |
https://ClinicalTrials.gov/show/NCT03329703 |
Recruiting |
Dartmouth-Hitchcock Medical Center |
2020-07-31 |
| NCT03313362 |
Detecting PNES With Single-channel sEMG |
https://ClinicalTrials.gov/show/NCT03313362 |
Active, not recruiting |
Brain Sentinel |
2019-06-21 |
| NCT03299842 |
A Study to Assess the Usability of the Embrace Seizure Detection Watch in Children and Young Adults With Dravet Syndrome |
https://ClinicalTrials.gov/show/NCT03299842 |
Enrolling by invitation |
Zogenix, Inc. |
2020-01-01 |
| NCT03288129 |
Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures |
https://ClinicalTrials.gov/show/NCT03288129 |
Active, not recruiting |
Eisai Inc. |
2021-04-27 |
| NCT03283371 |
Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy |
https://ClinicalTrials.gov/show/NCT03283371 |
Active, not recruiting |
Biogen |
2020-01-10 |
| NCT03250377 |
A Study to Test the Safety/ Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects >=16 Years of Age With Partial Seizures With or Without Secondary Generalization |
https://ClinicalTrials.gov/show/NCT03250377 |
Enrolling by invitation |
UCB Pharma |
2025-02-28 |
| NCT03233399 |
Modulating Movement Intention Via Cortical Stimulation |
https://ClinicalTrials.gov/show/NCT03233399 |
Recruiting |
NYU Langone Health |
2020-04-30 |
| NCT03228264 |
A Trial Investigating Telerehabilitation as an add-on to Face-to-face Speech and Language Therapy in Post-stroke Aphasia. |
https://ClinicalTrials.gov/show/NCT03228264 |
Recruiting |
University of Bern |
2021-11-30 |
| NCT03209323 |
Epileptiform EEG Patterns During Induction of General Anaesthesia With Sevoflurane Compared to Those With Propofol |
https://ClinicalTrials.gov/show/NCT03209323 |
Completed |
Medical University of Silesia |
2008-12-13 |
| NCT03207685 |
Generalized Seizure Detection And Alerting In The EMU With The Empatica Embrace Watch And Smartphone-Based Alert System |
https://ClinicalTrials.gov/show/NCT03207685 |
Recruiting |
Empatica, Inc. |
2019-06-26 |
| NCT03206502 |
Embrace: Seizure Characterization |
https://ClinicalTrials.gov/show/NCT03206502 |
Enrolling by invitation |
Empatica, Inc. |
2026-05-31 |
| NCT03201900 |
Study for Verification of Efficacy and Safety for Perampanel Monotherapy in Untreated Patients With Partial Onset Seizures (Including Secondarily Generalized Seizures) (FREEDOM Study) |
https://ClinicalTrials.gov/show/NCT03201900 |
Active, not recruiting |
Eisai Inc. |
2019-02-28 |
| NCT03198949 |
A Study Investigating the Anti-epileptic Efficacy of Afinitor (Everolimus) in Patients With Refractory Seizures Who Have Focal Cortical Dysplasia Type II (FCD II) |
https://ClinicalTrials.gov/show/NCT03198949 |
Recruiting |
Yonsei University |
2020-04-30 |
| NCT03198494 |
Acoustic Stimulation for Seizure Suppression |
https://ClinicalTrials.gov/show/NCT03198494 |
Enrolling by invitation |
NYU Langone Health |
2021-08-17 |
| NCT03191058 |
Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression |
https://ClinicalTrials.gov/show/NCT03191058 |
Active, not recruiting |
University of Texas Southwestern Medical Center |
2022-07-31 |
| NCT03181945 |
Duration of Anti-convulsant Therapy for Acute Symptomatic Seizure in Acute Encephalitis Syndrome |
https://ClinicalTrials.gov/show/NCT03181945 |
Active, not recruiting |
Postgraduate Institute of Medical Education and Research |
2018-09-30 |
| NCT03168542 |
Clinical Evaluation of Fitting Investigational Contact Lenses Phase 2 |
https://ClinicalTrials.gov/show/NCT03168542 |
Completed |
Johnson & Johnson Vision Care, Inc. |
2017-05-04 |
| NCT03165981 |
Fever After Simultaneous Versus Sequential Vaccination in Young Children |
https://ClinicalTrials.gov/show/NCT03165981 |
Completed |
Duke University |
2018-01-15 |
| NCT03160664 |
Magnetic Seizure Therapy for Bipolar Mania |
https://ClinicalTrials.gov/show/NCT03160664 |
Recruiting |
Shanghai Mental Health Center |
2021-03-31 |
| NCT03154307 |
Repeated TMS at Low Frequencies to Reduce Seizure Occurrence |
https://ClinicalTrials.gov/show/NCT03154307 |
Recruiting |
Baptist Health South Florida |
2023-12-31 |
| NCT03150485 |
Clinical Evaluation of Fitting Investigational Contact Lenses |
https://ClinicalTrials.gov/show/NCT03150485 |
Completed |
Johnson & Johnson Vision Care, Inc. |
2017-03-31 |
| NCT03138876 |
EEG Cap for Identification of Non-Convulsive Status Epilepticus |
https://ClinicalTrials.gov/show/NCT03138876 |
Completed |
Mayo Clinic |
2018-08-16 |
| NCT03126682 |
Effect of Bupropion on Seizure Threshold in Depressed Patients |
https://ClinicalTrials.gov/show/NCT03126682 |
Completed |
Duke University |
2018-05-31 |
| NCT03116828 |
A Study of a Drug to be Used in Addition With Another Drug to Treat Adults With Uncontrolled Partial-onset Seizures |
https://ClinicalTrials.gov/show/NCT03116828 |
Completed |
Sunovion |
2019-06-06 |
| NCT03098745 |
Fitting Evaluation of Hydrogel and Silicone Hydrogel Sphere Design Contact Lenses |
https://ClinicalTrials.gov/show/NCT03098745 |
Completed |
Coopervision, Inc. |
2017-03-01 |
| NCT03083665 |
A Study to Evaluate the Efficacy and Safety of Brivaracetam in Study Participants (>=16 to 80 Years of Age) With Epilepsy |
https://ClinicalTrials.gov/show/NCT03083665 |
Recruiting |
UCB Pharma |
2022-07-31 |
| NCT03071783 |
Intra-operative Feed Back on Traction Force During Vacuum Extraction: Safe Vacuum Extraction Alliance |
https://ClinicalTrials.gov/show/NCT03071783 |
Completed |
Karolinska Institutet |
2018-06-15 |
| NCT03048084 |
Seizure Treatment in Glioma |
https://ClinicalTrials.gov/show/NCT03048084 |
Recruiting |
Leiden University Medical Center |
2021-02-01 |
| NCT03021018 |
A Study to Assess the Efficacy and Safety of Brivaracetam as Treatment for Increased Seizure Activity in an Epilepsy Monitoring Unit Setting |
https://ClinicalTrials.gov/show/NCT03021018 |
Completed |
UCB Pharma |
2018-04-27 |
| NCT03003156 |
50 Hz vs. 25 Hz Magnetic Seizure Therapy for Schizophrenia |
https://ClinicalTrials.gov/show/NCT03003156 |
Completed |
Shanghai Mental Health Center |
2017-02-28 |
| NCT02976545 |
Emotional Lived in Patients Suffering From Psychogenic Nonepileptic Seizures : Study by Functional Magnetic Resonance Imaging |
https://ClinicalTrials.gov/show/NCT02976545 |
Recruiting |
Central Hospital, Nancy, France |
2021-10-31 |
| NCT02962414 |
Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued Treatment |
https://ClinicalTrials.gov/show/NCT02962414 |
Active, not recruiting |
Novartis |
2027-08-04 |
| NCT02960347 |
Examining the Efficacy of tDCS in the Attenuation of Epileptic Paroxysmal Discharges and Clinical Seizures |
https://ClinicalTrials.gov/show/NCT02960347 |
Completed |
Herzog Hospital |
2016-05-31 |
| NCT02929667 |
Abnormal Ventilatory Response to Carbon Dioxide: a Potential Biomarker for Seizure Induced Respiratory Depression & Modification by SSRI |
https://ClinicalTrials.gov/show/NCT02929667 |
Completed |
University of Iowa |
2019-03-06 |
| NCT02928159 |
Low Pulse Amplitude Seizure Therapy (LAP-ST Study) |
https://ClinicalTrials.gov/show/NCT02928159 |
Completed |
Behman Hospital |
2015-06-30 |
| NCT02899611 |
A Dose Ranging Pilot Study for Intracerebroventricular (ICV) Delivery of Valproate in Subjects With Temporal Seizures |
https://ClinicalTrials.gov/show/NCT02899611 |
Active, not recruiting |
Cerebral Therapeutics LLC |
2021-02-28 |
| NCT02897856 |
Efficacy and Safety of Intramuscular Midazolam Compared to Buccal Midazolam in Pediatric Seizures |
https://ClinicalTrials.gov/show/NCT02897856 |
Completed |
Hamad Medical Corporation |
2018-11-30 |
| NCT02881957 |
Hypovitaminosis D in Neurocritical Patients |
https://ClinicalTrials.gov/show/NCT02881957 |
Completed |
University of Utah |
2018-10-10 |
| NCT02850913 |
Doxycycline for the Treatment of Nodding Syndrome |
https://ClinicalTrials.gov/show/NCT02850913 |
Recruiting |
Makerere University |
2020-04-05 |
| NCT02834793 |
Study of Perampanel as Adjunctive Treatment for Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome |
https://ClinicalTrials.gov/show/NCT02834793 |
Recruiting |
Eisai Inc. |
2022-01-28 |
| NCT02801136 |
Treatment Outcomes of CBT for PNES |
https://ClinicalTrials.gov/show/NCT02801136 |
Recruiting |
University of Alabama at Birmingham |
2020-06-30 |
| NCT02796924 |
Treating Non-epileptic Seizures Using Magnetic Brain Stimulation |
https://ClinicalTrials.gov/show/NCT02796924 |
Completed |
University of Manitoba |
2019-04-30 |
| NCT02764476 |
Embodied Virtual Reality Therapy for Functional Neurological Symptom/ Conversion Disorder |
https://ClinicalTrials.gov/show/NCT02764476 |
Recruiting |
Stanford University |
2021-12-31 |
| NCT02761330 |
Cognitive Recovery After Electroconvulsive Therapy and General Anesthesia |
https://ClinicalTrials.gov/show/NCT02761330 |
Completed |
Washington University School of Medicine |
2019-09-11 |
| NCT02748915 |
Electrophysiological-based Estimation of Cochlear Implant Fitting |
https://ClinicalTrials.gov/show/NCT02748915 |
Recruiting |
Hospices Civils de Lyon |
2020-07-31 |
| NCT02727816 |
Non-dispensing Fitting Study Comparing the Clinical Performance Hydrogel Sphere Design Contact Lenses. |
https://ClinicalTrials.gov/show/NCT02727816 |
Completed |
Coopervision, Inc. |
2016-05-31 |
| NCT02726074 |
Trial Evaluating the Efficacy and Safety of Perampanel Added to Monotherapy in Participants With Partial Onset Seizures With or Without Secondary Generalization |
https://ClinicalTrials.gov/show/NCT02726074 |
Completed |
Eisai Inc. |
2018-04-26 |
| NCT02724423 |
Repeat-Dose Pharmacokinetics Study of NRL-1 in Epilepsy Subjects |
https://ClinicalTrials.gov/show/NCT02724423 |
Completed |
Neurelis, Inc. |
2019-04-10 |
| NCT02721069 |
Repeat Dose Safety Study of NRL-1 in Epilepsy Subjects |
https://ClinicalTrials.gov/show/NCT02721069 |
Recruiting |
Neurelis, Inc. |
2020-05-31 |
| NCT02700412 |
University of Alabama at Birmingham (UAB) Adult CBD Program |
https://ClinicalTrials.gov/show/NCT02700412 |
Completed |
University of Alabama at Birmingham |
2019-08-08 |
| NCT02695537 |
University of Alabama at Birmingham (UAB) Pediatric CBD Program |
https://ClinicalTrials.gov/show/NCT02695537 |
Completed |
University of Alabama at Birmingham |
2019-02-27 |
| NCT02598076 |
Motivational Interviewing to Enhance Adherence of Patients With Psychogenic Non-epileptic Seizures |
https://ClinicalTrials.gov/show/NCT02598076 |
Completed |
Brigham and Women’s Hospital |
2017-06-30 |
| NCT02408549 |
Safety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic Clonic Seizures |
https://ClinicalTrials.gov/show/NCT02408549 |
Active, not recruiting |
UCB Pharma |
2023-12-31 |
| NCT02569970 |
Efficacy of Fluoxetine Against Seizure-induced Central Apneas |
https://ClinicalTrials.gov/show/NCT02569970 |
Completed |
Hospices Civils de Lyon |
2010-12-31 |
| NCT03399318 |
Aggressive Antipyretics for Fever Reduction in CNS Malaria |
https://ClinicalTrials.gov/show/NCT03399318 |
Recruiting |
University of Rochester |
2022-03-31 |
| NCT02550028 |
Levetiracetam Treatment of Neonatal Seizures |
https://ClinicalTrials.gov/show/NCT02550028 |
Active, not recruiting |
Children’s Hospital of Fudan University |
2019-12-31 |
| NCT02544763 |
A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6) |
https://ClinicalTrials.gov/show/NCT02544763 |
Completed |
GW Research Ltd |
2019-01-22 |
| NCT02544750 |
An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6) |
https://ClinicalTrials.gov/show/NCT02544750 |
Enrolling by invitation |
GW Research Ltd |
2022-02-28 |
| NCT02535572 |
Focal Electrically-Administered Seizure Therapy (FEAST) Studies at Two Enrolling Sites to Further Test and Refine the Treatment |
https://ClinicalTrials.gov/show/NCT02535572 |
Completed |
Medical University of South Carolina |
2019-06-10 |
| NCT02535091 |
Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures |
https://ClinicalTrials.gov/show/NCT02535091 |
Active, not recruiting |
SK Life Science, Inc. |
2020-12-31 |
| NCT02484001 |
Eslicarbazepine Acetate (BIA 2-093) as Monotherapy in Patients With Newly Diagnosed Partial-onset Seizures |
https://ClinicalTrials.gov/show/NCT02484001 |
Completed |
Bial - Portela C S.A. |
2018-09-11 |
| NCT02477839 |
Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects ≥1 Month to <4 Years With Partial-onset Seizures |
https://ClinicalTrials.gov/show/NCT02477839 |
Completed |
UCB Pharma |
2020-05-28 |
| NCT02465047 |
Stress and Seizures - Can a Brief Self-help Book Help? |
https://ClinicalTrials.gov/show/NCT02465047 |
Completed |
Sheffield Teaching Hospitals NHS Foundation Trust |
2015-09-30 |
| NCT02458820 |
Prompt Diagnosis and Treatment of Subclinical Seizures After Cardiac Arrest |
https://ClinicalTrials.gov/show/NCT02458820 |
Completed |
Children’s Hospital of Philadelphia |
2019-01-31 |
| NCT02431780 |
A Multicentre Clinical Investigation of a Decision Support Algorithm for Neonatal Seizure Detection |
https://ClinicalTrials.gov/show/NCT02431780 |
Active, not recruiting |
University College Cork |
2017-02-28 |
| NCT02426047 |
Medium Chain Triglycerides as an Adjunct to the Modified Atkins Diet for Women With Catamenial Epilepsy |
https://ClinicalTrials.gov/show/NCT02426047 |
Completed |
Johns Hopkins University |
2020-01-31 |
| NCT02408523 |
A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications |
https://ClinicalTrials.gov/show/NCT02408523 |
Completed |
UCB Pharma |
2019-04-30 |
| NCT02369471 |
A Study of GWP42006 in People With Focal Seizures - Part A |
https://ClinicalTrials.gov/show/NCT02369471 |
Completed |
GW Research Ltd |
2015-10-31 |
| NCT02365610 |
A Study of GWP42006 in People With Focal Seizures - Part B |
https://ClinicalTrials.gov/show/NCT02365610 |
Completed |
GW Research Ltd |
2017-07-31 |
| NCT02363933 |
Perampanel in Seizure Patients With Primary Glial Brain Tumors |
https://ClinicalTrials.gov/show/NCT02363933 |
Completed |
Duke University |
2017-03-14 |
| NCT02341859 |
Lens Fitting Evaluation of CooperVision MyDay™ Compared With 1-DAY ACUVUE® TruEye® and DAILIES TOTAL1® |
https://ClinicalTrials.gov/show/NCT02341859 |
Completed |
Coopervision, Inc. |
2015-06-30 |
| NCT02339376 |
Treating Deep Seizure Foci With Noninvasive Surface Brain Stimulation |
https://ClinicalTrials.gov/show/NCT02339376 |
Active, not recruiting |
Beth Israel Deaconess Medical Center |
2020-01-31 |
| NCT02334722 |
1 Week Versus 6 Weeks of Levetiracetam in Surgical Brain Tumor Patients |
https://ClinicalTrials.gov/show/NCT02334722 |
Recruiting |
University of Florida |
2021-03-31 |
| NCT02332174 |
Pharmacokinetics and Tolerability of Rufinamide in Healthy Chinese Subjects |
https://ClinicalTrials.gov/show/NCT02332174 |
Completed |
Wuhan Union Hospital, China |
2014-06-30 |
| NCT02325544 |
Comparing Different Treatments in Reducing Dissociative Seizure Occurrence |
https://ClinicalTrials.gov/show/NCT02325544 |
Completed |
King’s College London |
2017-05-31 |
| NCT02324673 |
Cannabidiol Oral Solution in Pediatric Participants With Treatment-resistant Seizure Disorders |
https://ClinicalTrials.gov/show/NCT02324673 |
Completed |
INSYS Therapeutics Inc |
2016-05-09 |
| NCT02318602 |
Cannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure Disorder |
https://ClinicalTrials.gov/show/NCT02318602 |
Completed |
INSYS Therapeutics Inc |
2017-06-22 |
| NCT02229318 |
A Taste and Acceptance Study of FruitiVits in Children Aged 4-8 Years Following a Ketogenic Diet. |
https://ClinicalTrials.gov/show/NCT02229318 |
Completed |
Vitaflo International, Ltd |
2014-10-31 |
| NCT02224690 |
A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults |
https://ClinicalTrials.gov/show/NCT02224690 |
Completed |
GW Research Ltd |
2016-03-18 |
| NCT02216500 |
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy |
https://ClinicalTrials.gov/show/NCT02216500 |
Recruiting |
University of Florida |
2020-10-31 |
| NCT02224560 |
Efficacy and Safety of GWP42003-P for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults |
https://ClinicalTrials.gov/show/NCT02224560 |
Completed |
GW Research Ltd |
2016-05-19 |
| NCT02192814 |
Open-label Study to Evaluate the Safety and Tolerability of iv Lacosamide in Japanese Adults With Partial-onset Seizures |
https://ClinicalTrials.gov/show/NCT02192814 |
Completed |
UCB Pharma |
2014-10-31 |
| NCT02124564 |
A Trial to Evaluate the Long Term Safety and Tolerability of Lacosamide Taken as Monotherapy in Adults With Partial-onset Seizures |
https://ClinicalTrials.gov/show/NCT02124564 |
Completed |
UCB Pharma |
2017-11-21 |
| NCT03384628 |
An Evaluation Of The Fitting Success Rate Of Senofilcon A Soft Contact Lenses In Three Designs. |
https://ClinicalTrials.gov/show/NCT03384628 |
Completed |
Visioncare Research Ltd. |
2018-05-24 |
| NCT02072824 |
A Safety, Efficacy, and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric Subjects <4 Years of Age With Partial Onset Seizures. |
https://ClinicalTrials.gov/show/NCT02072824 |
Completed |
Pfizer |
2018-03-13 |
| NCT01292837 |
A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures |
https://ClinicalTrials.gov/show/NCT01292837 |
Completed |
UCB Pharma |
2013-06-30 |
| NCT01284556 |
Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset Seizures |
https://ClinicalTrials.gov/show/NCT01284556 |
Completed |
West-Ward Pharmaceutical |
2013-01-31 |
| NCT01278173 |
A Study of the Structure and Function of the Retina in Adult Patients With Refractory Complex Partial Seizures Treated With Vigabatrin (Sabril®) |
https://ClinicalTrials.gov/show/NCT01278173 |
Completed |
Lundbeck LLC |
2015-05-31 |
| NCT00616681 |
Bioequivalency Study of 600 mg Oxcarbazepine Tablets Under Fasting Conditions |
https://ClinicalTrials.gov/show/NCT00616681 |
Completed |
West-Ward Pharmaceutical |
2004-07-31 |
| NCT02019667 |
Phase 2 Clinical Trial of SGS-742 Therapy in Succinic Semialdehyde Dehydrogenase Deficiency |
https://ClinicalTrials.gov/show/NCT02019667 |
Completed |
National Institutes of Health Clinical Center (CC) |
2019-01-31 |
| NCT03325439 |
A Study to Test the Pharmacokinetics, Efficacy, and Safety of Brivaracetam in Newborns With Repeated Electroencephalographic Seizures |
https://ClinicalTrials.gov/show/NCT03325439 |
Recruiting |
UCB Pharma |
2021-12-31 |
| NCT01999777 |
Study to Evaluate the Safety and Efficacy of USL261 in Patients With Increased Bouts of Seizure Activity in the EMU |
https://ClinicalTrials.gov/show/NCT01999777 |
Completed |
UCB Pharma |
2015-08-31 |
| NCT01982812 |
A Safety and Feasibility Study of Enteral LVT vs. Standard of Care for Seizure Control in Pediatric CM |
https://ClinicalTrials.gov/show/NCT01982812 |
Completed |
University of Rochester |
2015-06-30 |
| NCT01977651 |
A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide |
https://ClinicalTrials.gov/show/NCT01977651 |
Completed |
Astellas Pharma Inc |
2016-02-01 |
| NCT01969851 |
A Study to Investigate the Safety and Efficacy of Lacosamide Added to the Patients Current Therapy in Patients Aged 1 Month to Less Than 18 Years Old With Epilepsy Syndromes Associated With Generalized Seizures. |
https://ClinicalTrials.gov/show/NCT01969851 |
Completed |
UCB Pharma |
2018-04-10 |
| NCT01963208 |
Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension |
https://ClinicalTrials.gov/show/NCT01963208 |
Completed |
Marinus Pharmaceuticals |
2016-05-31 |
| NCT01954121 |
Open-label, Randomized, Active-controlled Study of LEV Used as Monotherapy in Patients With Partial-Onset Seizures |
https://ClinicalTrials.gov/show/NCT01954121 |
Completed |
UCB Pharma |
2015-09-30 |
| NCT01941706 |
Preventing Depression in People With Epilepsy: an Extension of Project UPLIFT |
https://ClinicalTrials.gov/show/NCT01941706 |
Completed |
Emory University |
2011-12-31 |
| NCT01921205 |
Study to Investigate Lacosamide as Add-on Therapy in Subjects ≥4 Years to <17 Years of Age With Partial Onset Seizures |
https://ClinicalTrials.gov/show/NCT01921205 |
Completed |
UCB Pharma |
2017-01-24 |
| NCT01919307 |
Auricular Acupuncture For The Treatment Of Non-Epileptic Seizures |
https://ClinicalTrials.gov/show/NCT01919307 |
Completed |
Denver Health and Hospital Authority |
2016-01-31 |
| NCT01892605 |
The Clinical Application and Mechanism of Music Therapy (Mozart’s Effect) on Epilepsy |
https://ClinicalTrials.gov/show/NCT01892605 |
Completed |
Kaohsiung Medical University Chung-Ho Memorial Hospital |
2011-10-31 |
| NCT01866111 |
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures |
https://ClinicalTrials.gov/show/NCT01866111 |
Active, not recruiting |
SK Life Science, Inc. |
2015-07-31 |
| NCT01856335 |
Exercise Education for Adults With Seizure Disorders |
https://ClinicalTrials.gov/show/NCT01856335 |
Completed |
National Institutes of Health Clinical Center (CC) |
2017-01-25 |
| NCT01834482 |
Modified Atkins Diet Plus KetoCal for Adult Epilepsy |
https://ClinicalTrials.gov/show/NCT01834482 |
Completed |
Johns Hopkins University |
2017-09-30 |
| NCT01832038 |
Study to Evaluate the Safety, Tolerability, and Efficacy of Long-term Adjunctive Therapy With Lacosamide in Adults With Partial-onset Seizures |
https://ClinicalTrials.gov/show/NCT01832038 |
Completed |
UCB Pharma |
2019-07-31 |
| NCT01831063 |
A Simulation-based Intervention for Caregivers of Children With Seizures |
https://ClinicalTrials.gov/show/NCT01831063 |
Completed |
University of Calgary |
2012-12-31 |
| NCT01801072 |
Seizure Prophylaxis in Aneurysm Repair |
https://ClinicalTrials.gov/show/NCT01801072 |
Active, not recruiting |
University of Michigan |
2020-06-30 |
| NCT01796574 |
Ketogenic Diet for Refractory Status Epilepticus |
https://ClinicalTrials.gov/show/NCT01796574 |
Completed |
Johns Hopkins University |
2017-03-31 |
| NCT01777139 |
A Long-term, Safety, Tolerability, and Efficacy Study of Retigabine Immediate-release (IR) in Asian Adults With Partial Onset Seizures |
https://ClinicalTrials.gov/show/NCT01777139 |
Completed |
GlaxoSmithKline |
2016-12-14 |
| NCT01749046 |
Remegal Fixed Dose as Adjunctive Therapy in Patients With Partial Seizures |
https://ClinicalTrials.gov/show/NCT01749046 |
Completed |
Valexfarm |
2013-10-31 |
| NCT01720667 |
Efficacy of Intravenous Levetiracetam in Neonatal Seizures |
https://ClinicalTrials.gov/show/NCT01720667 |
Completed |
University of California, San Diego |
2017-10-31 |
| NCT01713946 |
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures |
https://ClinicalTrials.gov/show/NCT01713946 |
Completed |
Novartis |
2017-10-25 |
| NCT01710657 |
A Trial to Evaluate the Efficacy and Safety of Adjunctive Therapy With Lacosamide in Adults With Partial-Onset Seizures |
https://ClinicalTrials.gov/show/NCT01710657 |
Completed |
UCB Pharma |
2014-07-31 |
| NCT01703468 |
Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fed Conditions |
https://ClinicalTrials.gov/show/NCT01703468 |
Completed |
West-Ward Pharmaceutical |
2009-09-30 |
| NCT01702623 |
Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fasted Conditions |
https://ClinicalTrials.gov/show/NCT01702623 |
Completed |
West-Ward Pharmaceutical |
2009-09-30 |
| NCT01660672 |
Enteral Levetiracetam For Seizure Control In Pediatric Cerebral Malaria |
https://ClinicalTrials.gov/show/NCT01660672 |
Completed |
University of Rochester |
2013-07-31 |
| NCT01657084 |
Stopping and Preventing Epileptic Seizures Using a Partial Rebreathing Mask |
https://ClinicalTrials.gov/show/NCT01657084 |
Completed |
University of Aarhus |
2015-09-30 |
| NCT01630057 |
Evaluation of the Efficacy and Safety of Adjunctive Zonisamide vs Replacement With Zonisamide of the Last Added Antiepileptic Drug |
https://ClinicalTrials.gov/show/NCT01630057 |
Completed |
Eisai Inc. |
2011-06-30 |
| NCT01618695 |
A Study With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Perampanel (E2007) Administered as an Adjunctive Therapy in Subjects With Refractory Partial-onset Seizures |
https://ClinicalTrials.gov/show/NCT01618695 |
Active, not recruiting |
Eisai Inc. |
2014-09-15 |
| NCT01601314 |
Perioperative Magnesium Sulphate as a Cerebral Protector in Neurosurgical Patients |
https://ClinicalTrials.gov/show/NCT01601314 |
Completed |
Fundacion Clinic per a la Recerca Biomédica |
2017-12-31 |
| NCT01596608 |
Magnetic Seizure Therapy (MST) for Treatment Resistant Depression, Schizophrenia, and Obsessive Compulsive Disorder |
https://ClinicalTrials.gov/show/NCT01596608 |
Completed |
Centre for Addiction and Mental Health |
2019-06-30 |
| NCT00826722 |
Bioequivalency Study of Levetiracetam 1g Under Fasted Conditions |
https://ClinicalTrials.gov/show/NCT00826722 |
Completed |
West-Ward Pharmaceutical |
2007-06-30 |
| NCT01554683 |
Seizure Activity in Alzheimer’s Disease |
https://ClinicalTrials.gov/show/NCT01554683 |
Completed |
Beth Israel Deaconess Medical Center |
2017-07-01 |
| NCT01527513 |
Effects of Eslicarbazepine Acetate (Esl, Bia 2-093) on Cognitive Function in Children With Partial Onset Seizures |
https://ClinicalTrials.gov/show/NCT01527513 |
Completed |
Bial - Portela C S.A. |
2012-03-31 |
| NCT01515436 |
The Effect of Music Periodicity on Interictal Epileptiform Discharges |
https://ClinicalTrials.gov/show/NCT01515436 |
Completed |
Medical University of South Carolina |
2004-05-31 |
| NCT01506882 |
An Open Label Study of Levetiracetam Monotherapy in Patients With Newly Diagnosed Focal Epilepsy |
https://ClinicalTrials.gov/show/NCT01506882 |
Completed |
UCB Pharma |
2013-10-31 |
| NCT01463306 |
A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures |
https://ClinicalTrials.gov/show/NCT01463306 |
Completed |
Pfizer |
2019-08-22 |
| NCT01459692 |
Reduction and Prevention of Seizure Occurrence From Exposure to Auditory Stimulation in Individuals With Neurological Handicaps |
https://ClinicalTrials.gov/show/NCT01459692 |
Completed |
Medical University of South Carolina |
2008-01-31 |
| NCT01458522 |
Intravenous Lacosamide Compared With Fosphenytoin in the Treatment of Patients With Frequent Nonconvulsive Seizures |
https://ClinicalTrials.gov/show/NCT01458522 |
Completed |
Duke University |
2014-07-31 |
| NCT01441674 |
Animal Assisted Therapy in a Pediatric Setting |
https://ClinicalTrials.gov/show/NCT01441674 |
Completed |
Children’s Hospitals and Clinics of Minnesota |
2013-12-31 |
| NCT01434225 |
NEMO1:NEonatal Seizure Using Medication Off-patent |
https://ClinicalTrials.gov/show/NCT01434225 |
Completed |
Great Ormond Street Hospital for Children NHS Foundation Trust |
2013-06-30 |
| NCT01431976 |
Clinical Study of Lamotrigine to Treat Newly Diagnosed Typical Absence Seizure in Children and Adolescents |
https://ClinicalTrials.gov/show/NCT01431976 |
Completed |
GlaxoSmithKline |
2014-02-28 |
| NCT01422720 |
Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients |
https://ClinicalTrials.gov/show/NCT01422720 |
Completed |
Bial - Portela C S.A. |
2013-09-30 |
| NCT01417078 |
A Pharmacokinetic Study of a Single-Dose of Diazepam Nasal Spray in Adult Epileptic Patients Experiencing a Seizure Episode |
https://ClinicalTrials.gov/show/NCT01417078 |
Completed |
Acorda Therapeutics |
2013-02-28 |
| NCT01415362 |
Closed-loop System Using Transcranial Direct Current Stimulation (tDCS) for Epilepsy |
https://ClinicalTrials.gov/show/NCT01415362 |
Completed |
Spaulding Rehabilitation Hospital |
2014-07-31 |
| NCT01407523 |
An Open Label Study of L059 Intravenous (IV) in Japanese Epilepsy Subjects With Partial Onset Seizures |
https://ClinicalTrials.gov/show/NCT01407523 |
Completed |
UCB Pharma |
2012-02-29 |
| NCT01398956 |
An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures |
https://ClinicalTrials.gov/show/NCT01398956 |
Completed |
UCB Pharma |
2016-04-30 |
| NCT01397968 |
Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures |
https://ClinicalTrials.gov/show/NCT01397968 |
Active, not recruiting |
SK Life Science, Inc. |
2013-06-30 |
| NCT01393743 |
A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures |
https://ClinicalTrials.gov/show/NCT01393743 |
Completed |
Eisai Inc. |
2014-05-31 |
| NCT01392768 |
Efficacy and Safety of Levetiracetam in Partial Seizures Control, With or Without Secondary Generalization |
https://ClinicalTrials.gov/show/NCT01392768 |
Completed |
Ache Laboratorios Farmaceuticos S.A. |
2015-07-31 |
| NCT01389596 |
A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years |
https://ClinicalTrials.gov/show/NCT01389596 |
Completed |
Pfizer |
2016-08-10 |
| NCT01345097 |
A Short Metaphyseal Fitting Total Hip Arthroplasty in Young and Elderly Patients |
https://ClinicalTrials.gov/show/NCT01345097 |
Completed |
Ewha Womans University |
2006-03-31 |
| NCT01338805 |
Phase II BGG492 Capsule Extension for Partial Epilepsy |
https://ClinicalTrials.gov/show/NCT01338805 |
Completed |
Novartis |
2012-07-31 |
| NCT01336621 |
Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS) |
https://ClinicalTrials.gov/show/NCT01336621 |
Completed |
GlaxoSmithKline |
2016-12-14 |
| NCT01964560 |
Long-term Extension Study to Investigate Lacosamide as an Add-on Therapy in Children With Partial Onset Seizures |
https://ClinicalTrials.gov/show/NCT01964560 |
Active, not recruiting |
UCB Pharma |
2022-04-30 |
| NCT04325685 |
The Effect of Supraglottic and Oropharyngeal Decontamination on the Incidence of Ventilator-associated Pneumonia |
https://ClinicalTrials.gov/show/NCT04325685 |
Active, not recruiting |
Northern State Medical University |
2021-12-31 |
| NCT04323150 |
The Effect of Closed Suction System on the Incidence of Ventilator-associated Pneumonia. |
https://ClinicalTrials.gov/show/NCT04323150 |
Recruiting |
Northern State Medical University |
2020-12-31 |
| NCT04311151 |
Impact of Self-visualization of Epileptic Seizures on Patients’ Perception of the Disease and Risk Behavior |
https://ClinicalTrials.gov/show/NCT04311151 |
Completed |
Parc de Salut Mar |
2019-05-31 |
| NCT01325623 |
Seizure Detection and Automatic Magnet Mode Performance Study |
https://ClinicalTrials.gov/show/NCT01325623 |
Completed |
Cyberonics, Inc. |
2013-07-31 |
| NCT04266990 |
Olfactive Discriminative Ability of Dogs When Confronted With Seizure and Non-seizure Samples // Identification of Potential Biomarkers for Epilepsy in Human Sweat. |
https://ClinicalTrials.gov/show/NCT04266990 |
Recruiting |
University Hospital, Ghent |
2020-06-01 |
| NCT04244175 |
A Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures |
https://ClinicalTrials.gov/show/NCT04244175 |
Active, not recruiting |
Cerevel Therapeutics, LLC |
2021-09-01 |
| NCT04211233 |
Diagnostic Subdural EEG-electrode And Subdural hEmatoma (DISEASE) |
https://ClinicalTrials.gov/show/NCT04211233 |
Recruiting |
University Clinic Frankfurt |
2020-12-20 |
| NCT04158531 |
REC2Stim as a Treatment for Refractory Epilepsy in the Primary Sensorimotor Cortex. |
https://ClinicalTrials.gov/show/NCT04158531 |
Recruiting |
UMC Utrecht |
2022-03-31 |
| NCT04144439 |
Effect of GABA on ADHD and Seizures in Children With Epilepsy. |
https://ClinicalTrials.gov/show/NCT04144439 |
Recruiting |
Tanta University |
2028-12-01 |
| NCT04141891 |
Advancing Understanding of Transportation Options |
https://ClinicalTrials.gov/show/NCT04141891 |
Recruiting |
University of Colorado, Denver |
2023-08-01 |
| NCT04095182 |
Clinical Trial for Zebinix (Eslicarbazepine Acetate) in Healthy Korean and Caucasian Adult |
https://ClinicalTrials.gov/show/NCT04095182 |
Completed |
Whanin Pharmaceutical Company |
2019-12-16 |
| NCT04015141 |
A Study to Evaluate Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Participants With Childhood Epilepsy |
https://ClinicalTrials.gov/show/NCT04015141 |
Recruiting |
Eisai Inc. |
2021-10-13 |
| NCT03961568 |
Cenobamate Open-Label Extension Study for YKP3089C025 |
https://ClinicalTrials.gov/show/NCT03961568 |
Enrolling by invitation |
SK Life Science, Inc. |
2023-05-31 |
| NCT03954314 |
DEPOSITION - Decreasing Postoperative Blood Loss by Topical vs. Intravenous Tranexamic Acid in Open Cardiac Surgery |
https://ClinicalTrials.gov/show/NCT03954314 |
Recruiting |
Population Health Research Institute |
2021-11-30 |
| NCT03944447 |
Outcomes Mandate National Integration With Cannabis as Medicine |
https://ClinicalTrials.gov/show/NCT03944447 |
Recruiting |
OMNI Medical Services, LLC |
2025-12-31 |
| NCT03940326 |
Levetiracetam Versus Valproate in Idiopathic Generalized Tonic-clonic Seizures |
https://ClinicalTrials.gov/show/NCT03940326 |
Active, not recruiting |
Mazandaran University of Medical Sciences |
2019-10-01 |
| NCT03909984 |
Promoting Implementation of Seizure Detection Devices in Epilepsy Care |
https://ClinicalTrials.gov/show/NCT03909984 |
Recruiting |
Stichting Epilepsie Instellingen Nederland |
2021-12-31 |
| NCT03896386 |
EPIDOGS Digital Seizure Diary for Owners of Alerting Dogs |
https://ClinicalTrials.gov/show/NCT03896386 |
Recruiting |
University Hospital, Ghent |
2020-06-30 |
| NCT03882671 |
Development of a Minimally Invasive Seizure Gauge |
https://ClinicalTrials.gov/show/NCT03882671 |
Enrolling by invitation |
Seer Medical Pty Ltd |
2020-12-01 |
| NCT03790436 |
Betaquik as an Adjunct to Dietary Management of Epilepsy in Adults on the Modified Atkins Diet |
https://ClinicalTrials.gov/show/NCT03790436 |
Recruiting |
University of Southern California |
2020-12-30 |
| NCT03780907 |
Safety and Pharmacokinetics Study of E2007 to Treat Partial and Generalised Seizures in People With Epilepsy |
https://ClinicalTrials.gov/show/NCT03780907 |
Completed |
Eisai Inc. |
2003-08-06 |
| NCT03754582 |
A Study of Intravenous Perampanel in Japanese Participants With Epilepsy |
https://ClinicalTrials.gov/show/NCT03754582 |
Completed |
Eisai Inc. |
2019-12-10 |
| NCT03745118 |
Development of a Practical, Minimally Invasive Seizure Gauge |
https://ClinicalTrials.gov/show/NCT03745118 |
Enrolling by invitation |
Mayo Clinic |
2020-12-01 |
| NCT03742661 |
Impact of SPEAC® System Data on Therapeutic Decisions Related to Convulsive Seizure Patients With a New Diagnosis |
https://ClinicalTrials.gov/show/NCT03742661 |
Active, not recruiting |
Brain Sentinel |
2021-01-31 |
| NCT03722212 |
Early Diagnosis of the GLUT1 Deficiency Syndrome With a Blood Based Test |
https://ClinicalTrials.gov/show/NCT03722212 |
Recruiting |
METAFORA biosystems |
2020-12-31 |
| NCT03712475 |
Pharmacokinetics of Two Formulation of Pregabalin |
https://ClinicalTrials.gov/show/NCT03712475 |
Completed |
Yung Shin Pharm. Ind. Co., Ltd. |
2018-09-16 |
| NCT03685630 |
A Study to Evaluate the Safety and Tolerability of Intravenous Brivaracetam (BRV) as Replacement for Oral Brivaracetam in Japanese Subjects >=16 Years of Age With Partial Seizures With or Without Secondary Generalization |
https://ClinicalTrials.gov/show/NCT03685630 |
Recruiting |
UCB Pharma |
2021-03-31 |
| NCT03678753 |
Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in PGTC Seizures |
https://ClinicalTrials.gov/show/NCT03678753 |
Recruiting |
SK Life Science, Inc. |
2021-11-19 |
| NCT03676543 |
Mutual Interactions Between Absence Epilepsy Seizures and the Integration of Sensory Stimuli |
https://ClinicalTrials.gov/show/NCT03676543 |
Recruiting |
Fondation Ophtalmologique Adolphe de Rothschild |
2020-06-30 |
| NCT03631901 |
Comparison Between Melatonin and Diazepam for Prevention of Recurrent Simple Febrile Seizures |
https://ClinicalTrials.gov/show/NCT03631901 |
Completed |
Tanta University |
2018-09-01 |
| NCT03590197 |
Effect of Melatonin on Seizure Outcome, Neuronal Damage and Quality of Life in Patients With Generalized Seizure |
https://ClinicalTrials.gov/show/NCT03590197 |
Completed |
All India Institute of Medical Sciences, Bhubaneswar |
2020-03-03 |
| NCT03562351 |
Seizure Rescue Medication: Caregiver Education in a Simulation Setting |
https://ClinicalTrials.gov/show/NCT03562351 |
Recruiting |
Boston Children’s Hospital |
2021-05-31 |
| NCT03548779 |
North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2 |
https://ClinicalTrials.gov/show/NCT03548779 |
Recruiting |
University of North Carolina, Chapel Hill |
2021-05-31 |
| NCT03513757 |
Dexmedetomidine and Propofol for Pediatric MRI Sedation |
https://ClinicalTrials.gov/show/NCT03513757 |
Completed |
Medical College of Wisconsin |
2018-08-21 |
| NCT03484039 |
Incorporating Multidimensional Psychosocial Interventions Improves the Well-being of Individuals With Epilepsy |
https://ClinicalTrials.gov/show/NCT03484039 |
Recruiting |
University of Florida |
2021-02-28 |
| NCT03480555 |
Replacing Protein Via Enteral Nutrition in a Stepwise Approach in Critically Ill Patients |
https://ClinicalTrials.gov/show/NCT03480555 |
Completed |
King Abdullah International Medical Research Center |
2019-05-10 |
| NCT03478982 |
Inpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure Pattern |
https://ClinicalTrials.gov/show/NCT03478982 |
Active, not recruiting |
EngageTherapeutics, Inc. |
2019-12-31 |
| NCT03441867 |
Neuroimaging Biomarker for Seizures |
https://ClinicalTrials.gov/show/NCT03441867 |
Recruiting |
Providence VA Medical Center |
2021-03-31 |
| NCT03443388 |
Novel Helmet Design in Patients With Seizures |
https://ClinicalTrials.gov/show/NCT03443388 |
Completed |
University of Pennsylvania |
2019-12-15 |
| NCT03417297 |
A Pilot Study: Focused Ultrasound Thalamotomy for the Prevention of Secondary Generalization in Focal Onset Epilepsy |
https://ClinicalTrials.gov/show/NCT03417297 |
Recruiting |
Ohio State University |
2020-03-31 |
| NCT01262677 |
Once-A-Day Pregabalin For Partial Seizures |
https://ClinicalTrials.gov/show/NCT01262677 |
Completed |
Pfizer |
2012-07-31 |
| NCT01261325 |
Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures |
https://ClinicalTrials.gov/show/NCT01261325 |
Completed |
UCB Pharma |
2014-05-31 |
| NCT01239212 |
Dosing of Levetiracetam (Keppra) in Neonates |
https://ClinicalTrials.gov/show/NCT01239212 |
Completed |
Children’s Hospital Medical Center, Cincinnati |
2011-07-31 |
| NCT01229735 |
Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures |
https://ClinicalTrials.gov/show/NCT01229735 |
Completed |
UCB Pharma |
2015-05-31 |
| NCT01228747 |
A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures (Except Partial Seizures Evolving to Secondarily Generalized Seizures) |
https://ClinicalTrials.gov/show/NCT01228747 |
Completed |
UCB Pharma |
2014-04-30 |
| NCT01227902 |
Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures |
https://ClinicalTrials.gov/show/NCT01227902 |
Completed |
GlaxoSmithKline |
2012-12-31 |
| NCT01224457 |
Effect of CYP2C9/CYP2C19 Polymorphism on Pharmacokinetics of Phenobarbital in Korean Neonatal Seizure Patients. |
https://ClinicalTrials.gov/show/NCT01224457 |
Completed |
Yonsei University |
2010-04-30 |
| NCT01191086 |
Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures |
https://ClinicalTrials.gov/show/NCT01191086 |
Completed |
Upsher-Smith Laboratories |
2014-05-31 |
| NCT01179854 |
Remegal Different Doses in Patients With Refractory Partial Seizures |
https://ClinicalTrials.gov/show/NCT01179854 |
Completed |
Valexfarm |
2010-11-30 |
| NCT01162460 |
Efficacy and Safety of Eslicarbazepine Acetate as Monotherapy for Patients With Newly Diagnosed Partial-onset Seizures |
https://ClinicalTrials.gov/show/NCT01162460 |
Completed |
Bial - Portela C S.A. |
2016-09-30 |
| NCT01159431 |
External Trigeminal Nerve Stimulation for Epilepsy |
https://ClinicalTrials.gov/show/NCT01159431 |
Completed |
Olive View-UCLA Education & Research Institute |
2011-06-30 |
| NCT01147003 |
Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset Seizures |
https://ClinicalTrials.gov/show/NCT01147003 |
Completed |
Novartis |
2011-09-30 |
| NCT01142193 |
Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures |
https://ClinicalTrials.gov/show/NCT01142193 |
Completed |
Upsher-Smith Laboratories |
2012-12-31 |
| NCT01137110 |
Short Duration Levetiracetam to Extended Course for Seizure Prophylaxis After aSAH |
https://ClinicalTrials.gov/show/NCT01137110 |
Completed |
Washington University School of Medicine |
2013-01-01 |
| NCT01136954 |
A Study to Assess the Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Extension Study) |
https://ClinicalTrials.gov/show/NCT01136954 |
Completed |
Eisai Inc. |
2012-01-31 |
| NCT01118962 |
Open-Label Extension Study to Assess the Safety and Seizure Frequency Associated With Lacosamide for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy |
https://ClinicalTrials.gov/show/NCT01118962 |
Completed |
UCB Pharma |
2012-10-31 |
| NCT01118949 |
Open-Label Study to Assess Lacosamide Safety as Add-on Therapy for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy |
https://ClinicalTrials.gov/show/NCT01118949 |
Completed |
UCB Pharma |
2011-08-31 |
| NCT01116700 |
Dexmedetomidine in Seizure Patients |
https://ClinicalTrials.gov/show/NCT01116700 |
Completed |
University of California, San Francisco |
2012-02-29 |
| NCT01063764 |
An Open Label Study of Levetiracetam in Japanese Pediatric Patients With Partial Seizures |
https://ClinicalTrials.gov/show/NCT01063764 |
Completed |
UCB Pharma |
2011-04-30 |
| NCT01051193 |
Long-term Safety and Tolerability of TRI476 (Oxcarbazepine) in Children With Inadequately Controlled Partial Onset Seizures |
https://ClinicalTrials.gov/show/NCT01051193 |
Completed |
Nobelpharma |
2019-09-30 |
| NCT01027715 |
The Impact of Electroencephalographic (EEG) Seizure Treatment in Neonatal Encephalopathy |
https://ClinicalTrials.gov/show/NCT01027715 |
Completed |
Washington University School of Medicine |
2015-12-31 |
| NCT00991757 |
An Open-Label Extension Study to Evaluate the Safety and Tolerability of RWJ 333369 as Adjunctive Therapy in Patients 16 Years and Older With Partial Onset Seizures. |
https://ClinicalTrials.gov/show/NCT00991757 |
Completed |
SK Life Science, Inc. |
2010-10-31 |
| NCT00988429 |
Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures |
https://ClinicalTrials.gov/show/NCT00988429 |
Active, not recruiting |
Bial - Portela C S.A. |
2012-01-12 |
| NCT00988156 |
Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children |
https://ClinicalTrials.gov/show/NCT00988156 |
Completed |
Bial - Portela C S.A. |
2012-08-20 |
| NCT00975715 |
Efficacy, Safety and Tolerability of TRI476 (Oxcarbazepine) in Children With Inadequately Controlled Partial Onset Seizures |
https://ClinicalTrials.gov/show/NCT00975715 |
Completed |
Novartis |
2012-10-31 |
| NCT00973934 |
Magnetic Seizure Therapy (MST) for the Treatment of Major Depression |
https://ClinicalTrials.gov/show/NCT00973934 |
Completed |
Duke University |
2006-01-31 |
| NCT00957684 |
Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Seizures |
https://ClinicalTrials.gov/show/NCT00957684 |
Completed |
Bial - Portela C S.A. |
2005-11-30 |
| NCT00946751 |
To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions |
https://ClinicalTrials.gov/show/NCT00946751 |
Completed |
Sandoz |
2004-03-31 |
| NCT00938431 |
A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures |
https://ClinicalTrials.gov/show/NCT00938431 |
Completed |
UCB Pharma |
2014-08-31 |
| NCT00914680 |
Berlin Magnetic Seizure Therapy Depression Trial 01 |
https://ClinicalTrials.gov/show/NCT00914680 |
Completed |
Charite University, Berlin, Germany |
2012-05-31 |
| NCT00903786 |
A Long-term Extension Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-Epileptic Drugs (AEDs) |
https://ClinicalTrials.gov/show/NCT00903786 |
Completed |
Eisai Inc. |
2016-08-08 |
| NCT00887861 |
Efficacy of BGG492 in Individuals With Refractory Partial Seizures Undergoing Inpatient Evaluation for Epilepsy Surgery |
https://ClinicalTrials.gov/show/NCT00887861 |
Completed |
Novartis |
2010-08-31 |
| NCT00884052 |
Pharmacokinetic and Safety Trial of Intravenous Levetiracetam in the Treatment of Neonatal Seizures |
https://ClinicalTrials.gov/show/NCT00884052 |
Completed |
University of California, San Diego |
2011-03-31 |
| NCT00880204 |
Evaluation of Essential Surgical Skills-Emergency Maternal and Child Health Training |
https://ClinicalTrials.gov/show/NCT00880204 |
Completed |
Child Advocacy International |
2009-09-30 |
| NCT00871377 |
Double Blind, Crossover Study of Fish Oil [EPA and DHA] for Intractable Partial Seizures |
https://ClinicalTrials.gov/show/NCT00871377 |
Completed |
National Center for Complementary and Integrative Health (NCCIH) |
2011-05-31 |
| NCT00866775 |
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs |
https://ClinicalTrials.gov/show/NCT00866775 |
Completed |
Sunovion |
2013-05-31 |
| NCT00864006 |
Bioequivalence Study of Divalproex Sodium 125 MG Delayed Release Tablets Under Fasting Conditions |
https://ClinicalTrials.gov/show/NCT00864006 |
Completed |
Sandoz |
2006-10-31 |
| NCT00849212 |
An add-on Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-epileptic Drugs (AEDs) |
https://ClinicalTrials.gov/show/NCT00849212 |
Completed |
Eisai Inc. |
2009-11-30 |
| NCT00848549 |
Assessing The Long-Term Safety And To Explore The Long-Term Efficacy Of Zonisamide As Monotherapy In Newly Diagnosed Partial Seizures |
https://ClinicalTrials.gov/show/NCT00848549 |
Completed |
Eisai Inc. |
2011-06-30 |
| NCT03310697 |
Toxicological Screening by GC-MS Among Children Admitted for a First Afebrile Seizure |
https://ClinicalTrials.gov/show/NCT03310697 |
Recruiting |
University Hospital, Toulouse |
2020-12-31 |
| NCT00835627 |
Treatment Trial for Psychogenic Nonepileptic Seizures |
https://ClinicalTrials.gov/show/NCT00835627 |
Completed |
Rhode Island Hospital |
2012-12-31 |
| NCT00830531 |
Pilot Study of Bumetanide for Newborn Seizures |
https://ClinicalTrials.gov/show/NCT00830531 |
Completed |
Soul, Janet , M.D. |
2019-01-31 |
| NCT00827320 |
Bioequivalency Study of Levetiracetam 1g Tablets Under Fed Conditions |
https://ClinicalTrials.gov/show/NCT00827320 |
Completed |
West-Ward Pharmaceutical |
2007-06-30 |
| NCT00826865 |
Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fasting Conditions |
https://ClinicalTrials.gov/show/NCT00826865 |
Completed |
West-Ward Pharmaceutical |
2005-08-31 |
| NCT00826787 |
Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fed Conditions |
https://ClinicalTrials.gov/show/NCT00826787 |
Completed |
West-Ward Pharmaceutical |
2005-08-31 |
| NCT04219995 |
Pilot Trial to Evaluate The Effect of Oral Methylprednisolone on Seizure Frequency in Children With Epilepsy |
https://ClinicalTrials.gov/show/NCT04219995 |
Recruiting |
Louisiana State University Health Sciences Center in New Orleans |
2021-02-28 |
| NCT03054285 |
Does Short-Term Anti-Seizure Prophylaxis After Traumatic Brain Injury Decrease Seizure Rates? |
https://ClinicalTrials.gov/show/NCT03054285 |
Recruiting |
Loyola University |
2020-04-01 |
| NCT02849626 |
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures |
https://ClinicalTrials.gov/show/NCT02849626 |
Active, not recruiting |
Eisai Inc. |
2019-02-05 |
| NCT00808938 |
A Pilot Study of the Use of Magnetic Seizure Therapy for Depression |
https://ClinicalTrials.gov/show/NCT00808938 |
Completed |
Bayside Health |
2011-01-31 |
| NCT01747915 |
A Safety, Efficacy and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric and Adult Subjects With Primary Generalized Tonic-Clonic (i.e., Grand Mal) Seizures. |
https://ClinicalTrials.gov/show/NCT01747915 |
Completed |
Pfizer |
2019-02-20 |
| NCT03235115 |
Fitting Evaluation of Hydrogel and Silicone Hydrogel Spherical Contact Lenses |
https://ClinicalTrials.gov/show/NCT03235115 |
Completed |
Coopervision, Inc. |
2017-09-22 |
| NCT02705768 |
Effect of Carbamazepine and Oxcarbazepine on Serum Neuron-specific Enolase and S100B in Focal Seizures |
https://ClinicalTrials.gov/show/NCT02705768 |
Completed |
All India Institute of Medical Sciences, Bhubaneswar |
2017-02-28 |
| NCT02682927 |
A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome |
https://ClinicalTrials.gov/show/NCT02682927 |
Active, not recruiting |
Zogenix, Inc. |
2020-07-31 |
| NCT01869374 |
Study Comparing Magnetic Seizure Therapy (MST) to Electroconvulsive Therapy (ECT) for Depression in Older Adults |
https://ClinicalTrials.gov/show/NCT01869374 |
Active, not recruiting |
New York State Psychiatric Institute |
2017-07-31 |
| NCT01521130 |
Imaging the Effect of Centrotemporal Spikes and Seizures on Language in Children |
https://ClinicalTrials.gov/show/NCT01521130 |
Completed |
Children’s Hospital Medical Center, Cincinnati |
2017-07-31 |
| NCT00955357 |
Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures |
https://ClinicalTrials.gov/show/NCT00955357 |
Completed |
UCB Pharma |
2013-04-30 |
| NCT00789113 |
Determination of Absorption and Elimination of Lamotrigine-XR |
https://ClinicalTrials.gov/show/NCT00789113 |
Completed |
University of Minnesota |
2011-01-31 |
| NCT00772603 |
Evaluation of Efficacy and Safety of OXC XR as Adjunctive Therapy for Partial Seizures |
https://ClinicalTrials.gov/show/NCT00772603 |
Completed |
Supernus Pharmaceuticals, Inc. |
2010-04-30 |
| NCT00770783 |
Magnetic Seizure Therapy (MST) for Treatment Resistant Major Depression |
https://ClinicalTrials.gov/show/NCT00770783 |
Completed |
University Hospital, Bonn |
2013-09-30 |
| NCT00744731 |
An Open-Label Extension Study of the Safety and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures |
https://ClinicalTrials.gov/show/NCT00744731 |
Completed |
SK Life Science, Inc. |
2010-08-31 |
| NCT00740623 |
A Study of the Effectiveness, Safety, and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures. |
https://ClinicalTrials.gov/show/NCT00740623 |
Completed |
SK Life Science, Inc. |
2009-10-31 |
| NCT00735527 |
Nasal Versus Venous Lorazepam for Control of Acute Seizures in Children |
https://ClinicalTrials.gov/show/NCT00735527 |
Completed |
All India Institute of Medical Sciences, New Delhi |
2009-04-30 |
| NCT00735397 |
Evaluation of the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures |
https://ClinicalTrials.gov/show/NCT00735397 |
Completed |
Eisai Inc. |
2014-09-30 |
| NCT00700310 |
Evaluating Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures |
https://ClinicalTrials.gov/show/NCT00700310 |
Completed |
Eisai Inc. |
2009-08-31 |
| NCT00699582 |
To Evaluate The Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures |
https://ClinicalTrials.gov/show/NCT00699582 |
Completed |
Eisai Inc. |
2010-12-31 |
| NCT00699972 |
Evaluating the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures |
https://ClinicalTrials.gov/show/NCT00699972 |
Completed |
Eisai Inc. |
2010-10-19 |
| NCT00697918 |
Long Term Effectiveness and Safety Study for RWJ-333369 as Adjunctive Therapy in Korean and Japanese Patients With Partial Onset Seizures |
https://ClinicalTrials.gov/show/NCT00697918 |
Completed |
SK Life Science, Inc. |
2009-04-30 |
| NCT00659958 |
ZAGAL Study: Evaluating Effectiveness and Tolerability of Zonisamide as Adjunctive Therapy in Patients With Partial Onset Seizures Treated With Two Antiepileptic Drugs |
https://ClinicalTrials.gov/show/NCT00659958 |
Completed |
Eisai Inc. |
2009-09-30 |
| NCT00655551 |
Safety of Intravenous Lacosamide Dose Followed by Twice Daily Oral Lacosamide in Subjects With Partial-onset Seizures |
https://ClinicalTrials.gov/show/NCT00655551 |
Completed |
UCB Pharma |
2009-09-30 |
| NCT00655486 |
Study to Assess the Long-term Safety of Oral Lacosamide in Subjects With Partial-onset Seizures |
https://ClinicalTrials.gov/show/NCT00655486 |
Completed |
UCB Pharma |
2010-06-30 |
| NCT00643136 |
A Study of Lyrica as Treatment for Sleep Problems in Patients With Sleep Problems and Seizures |
https://ClinicalTrials.gov/show/NCT00643136 |
Completed |
Pfizer |
NA |
| NCT00629889 |
Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors |
https://ClinicalTrials.gov/show/NCT00629889 |
Completed |
Centre Hospitalier Universitaire Vaudois |
2012-05-31 |
| NCT00618436 |
Assess Safety and Efficacy of Levetiracetam(LEV;Keppra)for Seizure Prevention |
https://ClinicalTrials.gov/show/NCT00618436 |
Completed |
University of Cincinnati |
2009-09-30 |
| NCT00618046 |
Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed Conditions |
https://ClinicalTrials.gov/show/NCT00618046 |
Completed |
West-Ward Pharmaceutical |
2004-11-30 |
| NCT00616863 |
Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed Conditions |
https://ClinicalTrials.gov/show/NCT00616863 |
Completed |
West-Ward Pharmaceutical |
2004-07-31 |
| NCT00616759 |
The Effect on Cognition of Terminating ECT Induced Seizures With Propofol |
https://ClinicalTrials.gov/show/NCT00616759 |
Completed |
Loma Linda University |
2008-09-30 |
| NCT00615615 |
Efficacy and Tolerability of Levetiracetam Add-On Treatment in Refractory Pediatric Patients With Partial Onset Seizures |
https://ClinicalTrials.gov/show/NCT00615615 |
Completed |
UCB Pharma |
2003-03-31 |
| NCT00610454 |
Safety and Tolerability of Levetiracetam Intravenous 15 Minute Infusion in Subjects Suffering From Partial Onset Seizures |
https://ClinicalTrials.gov/show/NCT00610454 |
Completed |
UCB Pharma |
2004-08-31 |
| NCT00603473 |
A Phase III Open-Label Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures |
https://ClinicalTrials.gov/show/NCT00603473 |
Completed |
Pfizer |
2009-12-31 |
| NCT00596466 |
Extension Study Of Long-Term Safety And Efficacy Of Pregabalin As Monotherapy (Lyrica) In Patients With Partial Seizures |
https://ClinicalTrials.gov/show/NCT00596466 |
Completed |
Pfizer |
2011-12-31 |
| NCT00594945 |
Study of Intranasal Clonazepam in Adult Subjects With Epileptic Seizures |
https://ClinicalTrials.gov/show/NCT00594945 |
Completed |
Jazz Pharmaceuticals |
2008-12-31 |
| NCT00571155 |
Trial of Levetiracetam in Patients With Primary Brain Tumors and Symptomatic Seizures Who Undergo Surgery |
https://ClinicalTrials.gov/show/NCT00571155 |
Completed |
University Hospital Tuebingen |
2009-08-31 |
| NCT00568217 |
Antipyretics for Preventing Recurrences of Febrile Seizures |
https://ClinicalTrials.gov/show/NCT00568217 |
Completed |
University of Oulu |
NA |
| NCT00566254 |
Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study) |
https://ClinicalTrials.gov/show/NCT00566254 |
Completed |
Eisai Inc. |
2011-03-31 |
| NCT00552305 |
To Determine Tolerability and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures |
https://ClinicalTrials.gov/show/NCT00552305 |
Completed |
UCB Pharma |
2010-02-28 |
| NCT00545012 |
A Safety and Efficacy Follow-up Study With Levetiracetam in Children (4-17 Years Old) Suffering From Absence Seizures |
https://ClinicalTrials.gov/show/NCT00545012 |
Completed |
UCB Pharma |
2003-05-31 |
| NCT00537940 |
Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures |
https://ClinicalTrials.gov/show/NCT00537940 |
Completed |
Pfizer |
2013-07-31 |
| NCT00537238 |
Pregabalin Versus Levetiracetam In Partial Seizures |
https://ClinicalTrials.gov/show/NCT00537238 |
Completed |
Pfizer |
2012-05-31 |
| NCT00534378 |
Phase I Trail for Intramuscular Administration of Midazolam Using An Autoinjector |
https://ClinicalTrials.gov/show/NCT00534378 |
Completed |
U.S. Army Office of the Surgeon General |
NA |
| NCT00530855 |
Trial to Assess Long-term Lacosamide (LCM) Monotherapy Use and Safety of LCM Monotherapy and Adjunctive Therapy for Partial-onset Seizures |
https://ClinicalTrials.gov/show/NCT00530855 |
Completed |
UCB Pharma |
2014-12-31 |
| NCT00522275 |
Determine Safety and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures |
https://ClinicalTrials.gov/show/NCT00522275 |
Completed |
UCB Pharma |
2009-10-31 |
| NCT00520741 |
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures |
https://ClinicalTrials.gov/show/NCT00520741 |
Completed |
UCB Pharma |
2012-12-31 |
| NCT00518713 |
Clobazam in Patients With Lennox-Gastaut Syndrome |
https://ClinicalTrials.gov/show/NCT00518713 |
Completed |
Lundbeck LLC |
2009-12-31 |
| NCT00515619 |
Assess Safety and Efficacy of Lacosamide in Patients With Partial Seizures |
https://ClinicalTrials.gov/show/NCT00515619 |
Completed |
UCB Pharma |
2010-08-31 |
| NCT00510783 |
IV Keppra in the Emergency Department for Prevention of Early Recurrent Seizures |
https://ClinicalTrials.gov/show/NCT00510783 |
Completed |
Emory University |
2008-12-31 |
| NCT00500994 |
Neurobiology of Functional Movement Disorder and Non-Epileptic Seizures |
https://ClinicalTrials.gov/show/NCT00500994 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2021-12-31 |
| NCT00490035 |
Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures |
https://ClinicalTrials.gov/show/NCT00490035 |
Completed |
UCB Pharma |
2009-02-28 |
| NCT00488748 |
Magnetic Seizure Therapy (MST) for Severe Mood Disorder |
https://ClinicalTrials.gov/show/NCT00488748 |
Completed |
Duke University |
2012-08-31 |
| NCT00465517 |
A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures |
https://ClinicalTrials.gov/show/NCT00465517 |
Completed |
Marinus Pharmaceuticals |
2008-10-31 |
| NCT00464269 |
Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures |
https://ClinicalTrials.gov/show/NCT00464269 |
Completed |
UCB Pharma |
2008-12-31 |
| NCT00448916 |
Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures |
https://ClinicalTrials.gov/show/NCT00448916 |
Completed |
Pfizer |
2013-10-31 |
| NCT00437281 |
Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset Seizures |
https://ClinicalTrials.gov/show/NCT00437281 |
Completed |
Pfizer |
2012-11-30 |
| NCT00433667 |
A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures. |
https://ClinicalTrials.gov/show/NCT00433667 |
Completed |
SK Life Science, Inc. |
2007-10-31 |
| NCT00425282 |
A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures. |
https://ClinicalTrials.gov/show/NCT00425282 |
Completed |
SK Life Science, Inc. |
2007-10-31 |
| NCT00419393 |
Long Term Follow-up Study With Keppra XR (Levetiracetam XR) for Partial Seizures |
https://ClinicalTrials.gov/show/NCT00419393 |
Completed |
UCB Pharma |
2010-03-31 |
| NCT00419094 |
Conversion to Monotherapy Study With Keppra XR for Partial Seizures |
https://ClinicalTrials.gov/show/NCT00419094 |
Completed |
UCB Pharma |
2009-09-30 |
| NCT00416195 |
Exploring the Safety And Tolerability of Doses of E2007 up to a Maximum of 12 mg In Patients With Refractory Partial Seizures |
https://ClinicalTrials.gov/show/NCT00416195 |
Completed |
Eisai Inc. |
2008-02-29 |
| NCT00368472 |
4-Year Open-Label Extension Phase of the Parallel-Group Study of E2007 in Patients With Refractory Partial Seizures |
https://ClinicalTrials.gov/show/NCT00368472 |
Completed |
Eisai Inc. |
2014-06-30 |
| NCT00367432 |
A Long Term Follow up Administration Study of L059 (Levetiracetam) in Epilepsy Patients With Partial Onset Seizures |
https://ClinicalTrials.gov/show/NCT00367432 |
Completed |
UCB Pharma |
2010-12-31 |
| NCT00361010 |
A Pilot Study of Efficacy and Tolerability of Levetiracetam Monotherapy in Subjects With Childhood Absence Epilepsy |
https://ClinicalTrials.gov/show/NCT00361010 |
Completed |
The Cleveland Clinic |
2007-12-31 |
| NCT00351611 |
Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo |
https://ClinicalTrials.gov/show/NCT00351611 |
Recruiting |
Pfizer |
2020-11-11 |
| NCT00334958 |
Rufinamide Given as Adjunctive Therapy in Patients With Refractory Partial Seizures |
https://ClinicalTrials.gov/show/NCT00334958 |
Completed |
Eisai Inc. |
2009-05-31 |
| NCT00327717 |
Evaluating the Efficacy and Safety of Zonisamide in the Treatment of Partial Seizures |
https://ClinicalTrials.gov/show/NCT00327717 |
Completed |
Eisai Inc. |
2008-05-31 |
| NCT00326612 |
Intranasal Midazolam Versus Rectal Diazepam for Treatment of Seizures |
https://ClinicalTrials.gov/show/NCT00326612 |
Completed |
University of Utah |
2008-12-31 |
| NCT00319501 |
Efficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Intermittent Medical Intervention for Acute Repetitive Seizures. |
https://ClinicalTrials.gov/show/NCT00319501 |
Completed |
Pfizer |
2014-07-31 |
| NCT00318929 |
Tolerability and Efficacy of Depakote-extended Release in the Elderly |
https://ClinicalTrials.gov/show/NCT00318929 |
Completed |
Virginia Commonwealth University |
2008-01-31 |
| NCT00298532 |
OPALS Pediatric Study |
https://ClinicalTrials.gov/show/NCT00298532 |
Completed |
Ottawa Hospital Research Institute |
2007-01-31 |
| NCT00292461 |
A Study for Evaluating the Efficacy and Safety of Zonisamide and Lamotrigine (Lamictal) for Subjects With Refractory Simple Partial, Complex Partial or Partial With Secondary Generalized Seizures |
https://ClinicalTrials.gov/show/NCT00292461 |
Completed |
Eisai Inc. |
2009-08-31 |
| NCT00290823 |
Corticosteroids to Reduce Frequency of Seizures in Neurocysticercosis Patients |
https://ClinicalTrials.gov/show/NCT00290823 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2011-03-31 |
| NCT00288639 |
Lyrica (Pregabalin) Administered as an Add-on Therapy for Partial Seizures (LEADER). |
https://ClinicalTrials.gov/show/NCT00288639 |
Completed |
Pfizer |
2007-12-31 |
| NCT00285285 |
Point of Care Device Use in the Pediatric Emergency Department |
https://ClinicalTrials.gov/show/NCT00285285 |
Completed |
Yale University |
NA |
| NCT00280696 |
A Double-blind Confirmatory Trial of Levetiracetam in Epilepsy Patients With Partial Onset Seizures |
https://ClinicalTrials.gov/show/NCT00280696 |
Completed |
UCB Pharma |
2007-11-30 |
| NCT00275925 |
Safety and Efficacy of Oxcarbazepine Monotherapy in Adults With Partial Seizures |
https://ClinicalTrials.gov/show/NCT00275925 |
Completed |
Novartis |
NA |
| NCT00275912 |
Efficacy, Safety, and Tolerability of Oxcarbazepine Monotherapy in Children With Partial Seizures |
https://ClinicalTrials.gov/show/NCT00275912 |
Completed |
Novartis |
2007-09-28 |
| NCT00266604 |
A Study to Evaluate the Dosing, Effectiveness and Safety of Topiramate for the Treatment of Epilepsy |
https://ClinicalTrials.gov/show/NCT00266604 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
NA |
| NCT00266591 |
A Study of the Efficacy and Safety of Topiramate Treatment in Patients With Epilepsy |
https://ClinicalTrials.gov/show/NCT00266591 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
NA |
| NCT00236886 |
Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy Patients |
https://ClinicalTrials.gov/show/NCT00236886 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
NA |
| NCT00236873 |
A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures. |
https://ClinicalTrials.gov/show/NCT00236873 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
NA |
| NCT00236860 |
A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures |
https://ClinicalTrials.gov/show/NCT00236860 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
NA |
| NCT00236847 |
A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Epilepsy. |
https://ClinicalTrials.gov/show/NCT00236847 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
NA |
| NCT00236756 |
A Study of the Efficacy and Safety of Topiramate as an add-on Therapy in the Treatment of Epilepsy Patients With Lennox-Gastaut Syndrome |
https://ClinicalTrials.gov/show/NCT00236756 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
NA |
| NCT00236743 |
A Study of the Effectiveness and Safety of Topiramate in the Treatment of Children With Epilepsy |
https://ClinicalTrials.gov/show/NCT00236743 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
NA |
| NCT00236730 |
A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Difficult to Control Epilepsy |
https://ClinicalTrials.gov/show/NCT00236730 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
NA |
| NCT00236717 |
A Study of the Effectiveness and Safety of Topiramate Compared With a Standard Therapy in Patients Newly Diagnosed With Epilepsy |
https://ClinicalTrials.gov/show/NCT00236717 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
NA |
| NCT00236704 |
A Study of the Efficacy and Safety of Topiramate as “Add on” Treatment in Epilepsy Patients With Primary Generalized Tonic-clonic Seizures |
https://ClinicalTrials.gov/show/NCT00236704 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
NA |
| NCT00236691 |
A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures. |
https://ClinicalTrials.gov/show/NCT00236691 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
NA |
| NCT00236418 |
A Study of the Efficacy and Safety of Topiramate in Epilepsy Patients With Primary Generalized Tonic-clonic Seizures |
https://ClinicalTrials.gov/show/NCT00236418 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
NA |
| NCT00235755 |
Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy |
https://ClinicalTrials.gov/show/NCT00235755 |
Completed |
GlaxoSmithKline |
2008-04-30 |
| NCT00233012 |
A Study of the Pharmacokinetics, Safety and Tolerability of Topiramate in Infants (Age 1-24 Months) With Refractory Partial-onset Seizures |
https://ClinicalTrials.gov/show/NCT00233012 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
NA |
| NCT00232596 |
Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy |
https://ClinicalTrials.gov/show/NCT00232596 |
Completed |
GlaxoSmithKline |
2008-01-31 |
| NCT00231556 |
A Study on Safety and Efficacy of Two Doses of Topiramate as Monotherapy in the Treatment of Newly Diagnosed or Recurrent Epilepsy |
https://ClinicalTrials.gov/show/NCT00231556 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
NA |
| NCT00230698 |
A Study of the Effectiveness and Safety of Topiramate Monotherapy in Patients With Recently Diagnosed Partial-Onset Seizure |
https://ClinicalTrials.gov/show/NCT00230698 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
NA |
| NCT00220415 |
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Trial to Investigate the Efficacy and Safety of SPM 927 (200mg/Day and 400mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization |
https://ClinicalTrials.gov/show/NCT00220415 |
Completed |
UCB Pharma |
2006-01-31 |
| NCT00215592 |
Open Label, Zonegran (Zonisamide) In Partial Onset Seizures |
https://ClinicalTrials.gov/show/NCT00215592 |
Completed |
Eisai Inc. |
2007-07-31 |
| NCT00179517 |
Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole or Placebo |
https://ClinicalTrials.gov/show/NCT00179517 |
Completed |
Beth Israel Deaconess Medical Center |
2008-04-30 |
| NCT00175929 |
A Study of Brivaracetam in Subjects With Partial Onset Seizures |
https://ClinicalTrials.gov/show/NCT00175929 |
Completed |
UCB Pharma |
2006-03-31 |
| NCT00175890 |
A Placebo-controlled Study of Levetiracetam In Children (1mo to 4yrs of Age) With Partial Onset Seizures. |
https://ClinicalTrials.gov/show/NCT00175890 |
Completed |
UCB Pharma |
2007-01-31 |
| NCT00175825 |
A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures. |
https://ClinicalTrials.gov/show/NCT00175825 |
Completed |
UCB Pharma |
2006-06-29 |
| NCT00162981 |
Clobazam in Subjects With Lennox-Gastaut Syndrome |
https://ClinicalTrials.gov/show/NCT00162981 |
Completed |
Lundbeck LLC |
2006-08-31 |
| NCT00160615 |
Follow-up Study of L059 (Levetiracetam) in Epileptic Patients With Partial Onset Seizures by Open Label Method |
https://ClinicalTrials.gov/show/NCT00160615 |
Completed |
UCB Pharma |
2007-01-17 |
| NCT00160550 |
Study to Evaluate the Safety and Efficacy of Levetiracetam in Patients Suffering From Idiopathic Generalized Epilepsy With Primary Generalized Tonic-clonic Seizures |
https://ClinicalTrials.gov/show/NCT00160550 |
Completed |
UCB Pharma |
2005-06-30 |
| NCT00159965 |
Treatments for Psychogenic Nonepileptic Seizures (NES) |
https://ClinicalTrials.gov/show/NCT00159965 |
Completed |
Rhode Island Hospital |
2008-06-30 |
| NCT00152516 |
Long-Term, Follow-Up Study Of the Safety And Efficacy Of Levetiracetam In Children With Partial Onset Seizures |
https://ClinicalTrials.gov/show/NCT00152516 |
Completed |
UCB Pharma |
2008-06-30 |
| NCT00152503 |
Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam |
https://ClinicalTrials.gov/show/NCT00152503 |
Completed |
UCB Pharma |
2007-01-31 |
| NCT00152451 |
Study With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset Seizures |
https://ClinicalTrials.gov/show/NCT00152451 |
Completed |
UCB Pharma |
2007-01-31 |
| NCT00151879 |
Safety and Tolerability of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial Seizures |
https://ClinicalTrials.gov/show/NCT00151879 |
Completed |
UCB Pharma |
2006-05-31 |
| NCT00150293 |
Evaluation of Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures. |
https://ClinicalTrials.gov/show/NCT00150293 |
Completed |
Pfizer |
NA |
| NCT00147030 |
TOBY (TOtal Body hYpothermia): a Study of Treatment for Perinatal Asphyxia |
https://ClinicalTrials.gov/show/NCT00147030 |
Completed |
Imperial College London |
2006-11-30 |
| NCT00144872 |
LAMICTAL (Lamotrigine) For The Treatment Of Absence Seizures |
https://ClinicalTrials.gov/show/NCT00144872 |
Completed |
GlaxoSmithKline |
2006-04-22 |
| NCT00144690 |
E2007 Given as Adjunctive Therapy in Patients With Refractory Partial Seizures |
https://ClinicalTrials.gov/show/NCT00144690 |
Completed |
Eisai Inc. |
2007-02-28 |
| NCT00143143 |
Pregabalin Open-Label Extension Trial in Patients With Partial Seizures |
https://ClinicalTrials.gov/show/NCT00143143 |
Completed |
Pfizer |
NA |
| NCT00143130 |
Pregabalin In Partial Seizures Extension Study |
https://ClinicalTrials.gov/show/NCT00143130 |
Completed |
Pfizer |
NA |
| NCT00141427 |
Pregabalin In Partial Seizures: An Open-Label, International, Multicenter Add-On Therapy Trial. |
https://ClinicalTrials.gov/show/NCT00141427 |
Completed |
Pfizer |
NA |
| NCT00141388 |
To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures |
https://ClinicalTrials.gov/show/NCT00141388 |
Completed |
Pfizer |
NA |
| NCT00141336 |
To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures. |
https://ClinicalTrials.gov/show/NCT00141336 |
Completed |
Pfizer |
NA |
| NCT00141258 |
Pregabalin Epilepsy Add-On Trial |
https://ClinicalTrials.gov/show/NCT00141258 |
Completed |
Pfizer |
NA |
| NCT00141245 |
To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures. |
https://ClinicalTrials.gov/show/NCT00141245 |
Completed |
Pfizer |
NA |
| NCT00136019 |
SPM 927 (400mg/Day and 600mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization |
https://ClinicalTrials.gov/show/NCT00136019 |
Completed |
UCB Pharma |
2006-08-31 |
| NCT00116064 |
Intranasal Lorazepam Versus Intramuscular Paraldehyde in Paediatric Convulsions |
https://ClinicalTrials.gov/show/NCT00116064 |
Completed |
University of Malawi College of Medicine |
NA |
| NCT00113815 |
Topiramate as Adjunctive Therapy in Infants 1-24 Months for the Control of Partial Onset Seizures |
https://ClinicalTrials.gov/show/NCT00113815 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
2007-06-30 |
| NCT00113165 |
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures |
https://ClinicalTrials.gov/show/NCT00113165 |
Completed |
GlaxoSmithKline |
2007-07-31 |
| NCT00105040 |
A 19-week Cognition Study of Levetiracetam in Children With Partial Onset Seizures |
https://ClinicalTrials.gov/show/NCT00105040 |
Completed |
UCB Pharma |
2007-03-31 |
| NCT00104416 |
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Primary Generalized Tonic-Clonic Seizures (PGTC) Seizures |
https://ClinicalTrials.gov/show/NCT00104416 |
Completed |
GlaxoSmithKline |
2008-07-31 |
| NCT00102713 |
A Study for Treatment of Partial Seizures in Children |
https://ClinicalTrials.gov/show/NCT00102713 |
Completed |
Abbott |
NA |
| NCT00088452 |
Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study |
https://ClinicalTrials.gov/show/NCT00088452 |
Completed |
Children’s Hospital Medical Center, Cincinnati |
2013-01-31 |
| NCT00067210 |
Reducing Seizure Frequency Using Cooling of the Head and Neck |
https://ClinicalTrials.gov/show/NCT00067210 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00034814 |
Multicenter Trial for Adults With Partial Seizures |
https://ClinicalTrials.gov/show/NCT00034814 |
Completed |
Teva Pharmaceutical Industries |
2006-01-31 |
| NCT00043901 |
Treatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New Drug |
https://ClinicalTrials.gov/show/NCT00043901 |
Completed |
GlaxoSmithKline |
2003-11-01 |
| NCT00040326 |
Early Surgical Intervention to Treat Epilepsy |
https://ClinicalTrials.gov/show/NCT00040326 |
Completed |
University of California, Los Angeles |
2007-11-30 |
| NCT00007670 |
Does Gabapentin and Lamotriginel Have Significantly Fewer Side-Effects While Providing Equal or Better Seizure Control Than the Current Drug Choice, Carbamazepine, for the Treatment of Seizures in the Elderly. |
https://ClinicalTrials.gov/show/NCT00007670 |
Completed |
VA Office of Research and Development |
NA |
| NCT00004817 |
Phase III Double Blind Trial of Valproate Sodium for Prophylaxis of Post Traumatic Seizures |
https://ClinicalTrials.gov/show/NCT00004817 |
Completed |
Office of Rare Diseases (ORD) |
NA |
| NCT00004729 |
Ketogenic Diet for Child Epilepsy and Seizure Control |
https://ClinicalTrials.gov/show/NCT00004729 |
Completed |
National Institute of Neurological Disorders and Stroke (NINDS) |
NA |